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ARTICLE
Validity of the Brazilian version of  
the freezing of gait questionnaire
Validação da versão brasileira da escala de congelamento da marcha
Jussara A. Oliveira Baggio, Mônica B. Curtarelli, Guilherme R. Rodrigues, Vitor Tumas
Freezing of gait (FOG) is a common and disabling symp-
tom in patients with Parkinson’s disease (PD). It is character-
ized by a sudden inability to initiate or to continue walking, 
and is described by patients as a situation in which their feet 
seem to be “stuck to the ground” despite attempts to walk1. 
There are some situations where FOG is more commonly in-
duced, such as at the initiation of gait, during turning while 
walking, as passing through narrow spaces, or immediately 
before reaching a destination2. However, the clinical presen-
tation of FOG is very variable, unpredictable, and has com-
plex relationship with the antiparkinsonian medications1,3. It 
also depends on the psychological state of the patient that 
may be distinctly influenced by the degree of stressful condi-
tions and by the balance between attention and distraction 
during walking2. FOG may be a challenge for clinicians, since 
in many times it may be difficult to identify and assess the 
problem. For the clinical diagnosis, it is recommended to di-
rect the history taking specifically for the presence of freezing, 
and to evaluate gait during a trajectory that features specific 
triggers to elicit FOG in ON and OFF state3.
Recently, Giladi et al.4 developed a clinical questionnaire 
to assess FOG in parkinsonian patients. The freezing of gait 
questionnaire (FOG-Q) has 6 questions and the total score 
ranges from 0 to 24; higher scores correspond to more se-
vere FOG. It is a useful tool for history taking of clinical data 
suggesting the presence of freezing. The item 3 of the scale 
directly assesses the presence of freezing. This scale proved 
to be reliable to screen and measure the severity of FOG in 
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ABSTRACT
Objective: To validate the freezing of gait questionnaire (FOG-Q) for a Brazilian population of Parkinson’s disease (PD) patients. Methods: One 
hundred and seven patients with a diagnosis of PD were evaluated by shortened UPDRS motor scale (sUPDRm), Hoehn and Yahr (HY), Schwab 
and England scale (SE), Berg balance scale (BBS), falls efficacy scale international (FES-I), gait and balance scale (GABS), and the FOG-Q 
Brazilian version. Results: 47.7% of PD patients had FOG episodes; this group had worse scores on sUPDRSm, FOGQ, FES-I, BBS, GABS and 
FOG item of UPDRS when compared to the PD group without FOG. The internal consistency was 0.86, intra-rater 0.82 and inter-rater 0.78. 
The FOG-Q Brazilian version was significantly correlated with items related to gait and balance. The ROC curve was 0.94, the sensitivity was 
0.90and specificity was 0.92. Conclusion: Our study suggests that the FOG-Q Brazilian version is a reliable and valid instrument for assessing 
FOG in PD patients.
Key words: gait, freezing, scale, validation studies, Parkinson’s disease.
RESUMO
Objetivo: Validar a escala de congelamento da marcha (FOG-Q) para a população brasileira com doença de Parkinson (DP). Métodos: Cento e 
sete pacientes com diagnóstico de DP foram avaliados através da versão reduzida da escala UPDRS motora (UPDRSm), HY (Hoehn e Yahr), SE 
(Schwab e England), escala de equilíbrio de Berg (BBS), escala internacional de medo de quedas (FES-I), escala de marcha e equilíbrio (GABS) 
e FOG-Q. Resultados: 47,7% dos pacientes com DP foram identificados com congelamento da marcha. Este grupo obteve resultados signifi-
cativamente piores nas UPDRSm, FOGQ, FES-I, BBS, GABS e no item de congelamento da UPDRS em comparação ao grupo sem o sintoma. 
A consistência interna da escala foi 0,86, a confiabilidade inter-examinador 0,82 e intra-examinador 0,78. Curva ROC de 0,94, sensibilidade 
0,90 e especificidade 0,92. Conclusão: Nosso estudo demonstra que a versão brasileira da escala de congelamento da marcha é válida para 
avaliar o congelamento da marcha em pacientes com DP.
Palavras-Chave: marcha, congelamento, estudos de validação, doença de Parkinson.
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patients with PD, and also to assess treatment interventions4. 
The main limitation of this approach is that it does not in-
clude the definite identification of freezing, hereby, the pres-
ence of false-positive and negative freezers cannot be totally 
excluded. The main objective of this study was to validate a 
Brazilian version of the FOG-Q.
METHODS
Cross-cultural adaptation of the FOG-Q
We obtained authorization from the original authors to 
validate the scale. The FOG-Q was independently translated by 
two health professionals that were native Portuguese speakers 
and well acquainted with the English language (J.A.O.B. and 
V.T.). The two translated versions were then compared and 
adapted to get a final consensual version. Then, this version 
was back-translated into English by a native English speaker 
that was familiar with the Portuguese language and who had 
not previous contact with the original version of the scale. The 
back-translated version was compared to the original version 
of the FOG-Q by the translators, who examined the differences 
and made consensual modifications.
Patients
We evaluated 107 patients with a diagnosis of PD accord-
ing to the UK Brain Bank diagnostic criteria that consecu-
tively attended the Movement Disorders Outpatient Clinic of 
the Ribeirão Preto School of Medicine.
We excluded patients with other associated motor dis-
orders (e.g., stroke), dementia according to the DSM-IV di-
agnostic criteria, concomitant severe systemic illness, acute 
disorders or injuries, severe sensorial deficits (e.g., blindness) 
or evident peripheral neuropathy, and orthopedic conditions 
that could interfere with gait.
This study was approved by ethics committee of 
Universidade de São Paulo (Comitê de Ética em Pesquisa — 
CEP — Protocol nº 2.913/2008). Written informed consent 
was obtained from all of the subjects.
Clinical assessments
The patients were all evaluated during the ON state, firstly 
by a neurologist that used the Hoehn and Yahr staging (HY)5 
and the Schwab and England functional scale (SE)6. He also 
rated the patient’s signs and symptoms using a shortened ver-
sion of the unified Parkinson’s disease rating scale (UPDRS), 
which included a motor score that measured the same mo-
tor signs as the short Parkinson’s evaluation scale but with the 
original five-point score of the UPDRS7. This shortened ver-
sion of the UPDRS motor scale (sUPDRSm) was shown to have 
good reliability and validity in Brazilian patients with PD7.
After that, one of the authors ( J.A.O.B.) interviewed the 
patients and recorded demographic and clinical information 
and history of falls in the previous twelve months. A “fall” was 
defined as an event resulting in a person coming to rest unin-
tentionally on the ground or on another level8.
Subsequently, the same examiner described for the 
patient a FOG episode as a situation in which their feet 
seem to be “stuck to the ground”. In some cases, it was nec-
essary to demonstrate a FOG episode to be sure that the pa-
tient understood what it is. After that, the examiner applied 
the FOG-Q and the patients completed the falls efficacy scale 
international (FES-I)9. This scale was previously validated 
for the Brazilian population and it is a self-administered tool 
that measures the concern about falling during the perfor-
mance of a range of daily living activities10. Patients were also 
evaluated by the same examiner using the Brazilian version 
of the Berg balance scale (BBS)11 and the clinical gait and bal-
ance scale (GABS). The GABS include a specific item (item 
22) to evaluate the presence of freezing during a provocative 
maneuver of rising from a chair, walking 5 meters between 2 
chairs spaced 24 in. apart, turning 180°, and walking back and 
sitting down. The total score vary from 0 to 5, and a score of 1 
is already indicative for the presence of freezing.
Ten patients were evaluated by the same examiner one 
week apart for the determination of intra-rater reliability and 
they were also evaluated by other examiner for determina-
tion of inter-rater reliability.
The definite presence of FOG to classify the patient as 
a freezer was based on the final clinical impression of the 
examiners and it was grounded in the score of item 14 of 
UPDRS (score >0) or in the observation of FOG during test-
ing the item 22 of GABS.
Statistical analysis
Descriptive statistics was used to analyze the clinical and 
demographic characteristics of all participants. For compari-
sons between groups, we used the Mann-Whitney test.
The internal reliability of the FOG-Q Brazilian version 
was assessed using Cronbach’s alpha, and item analyses were 
conducted by examining the effect on Cronbach’s alpha of ex-
cluding each of the six FOG-Q items individually. Values >0.70 
were considered to be acceptable. The test-retest reliability 
was assessed using intraclass correlation coefficient (ICC) 
and stability was considered acceptable when values ≥0.70 
for inter- and intra-rater reliability were reached.
Convergent validity represents the extent to which a 
measure is related to other variables conceptually associ-
ated with the same construct, and was evaluated by means 
of Spearman rank correlation coefficient (rs). We calculated 
the correlation between the FOG-Q scores and the single 
UPDRS item specifically addressing FOG (Part II – ADL item 
14), the freezing item of the GABS (item 22), the sum score of 
the axial items of the sUPDRSm (speech, rising from a chair, 
gait and  postural stability), and with other clinical instru-
ments and demographic data.
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We calculated the area under the receiver operating char-
acteristics (ROC) curve for the total score of the FOG-Q.
We made comparisons between FOG-Q item 3, UPDRS 
Part II (ADL-FOG) item 14 and FOG item of the GABS 
(item 22) using Kappa static.
The level of statistical significance was set at p<0.05.
RESULTS
The 107 patients with PD evaluated had a median age of 
62 years (range 33–83), a median of 7 years of disease dura-
tion (range 3–28), a median HY stage of 2 (range 1–4) and a 
median SE score of 80 (range 30–100).
Based on the final clinical impression, 51 patients (47.7%) 
with PD were classified as freezers and 56 patients (52.3%) 
were diagnosed as non-freezers. The clinical and demograph-
ic characteristics of these patients are presented in Table 1.
Internal consistency of the FOG-Q as measured by 
Cronbach’s alpha was 0.86 and item analysis indicated that 
all FOG-Q items contributed to these high reliability values, 
since the exclusion of any of the items from the scale would 
not reduce alpha to below this value.
Test-retest and inter-rater reliability of the FOG-Q total 
score were respectively 0.78 and 0.82.
The correlation coefficients between the FOG-Q and the 
other clinical evaluations are summarized in Table 2. The 
Patients with PD
p-valueNon-freezers n=56 (52.3%)
Freezers 
n=51 (47.7%)
Mean (SD) Median Mean (SD) Median
Age 63.9 (11.2) 65 59.7 (12.0) 60 0.08
Disease duration 7.2 (5.2) 7 9.0 (4.2) 7 0.002*
Hoehn and Yahr stage 2.1 (0.8) 2 2.3 (0.7) 2.5 0.1
Schwab and England scale 81.3 (13.3) 90 78.0 (13.2) 80 0.06
sUPDRSm 11.4 (6.2) 10 13.8 (6.7) 12 0.05
FOG-Q 2.3 (2.8) 3 9.9 (4.0) 6 0.0001*
UPDRS Part II (ADL-FOG) (item 14) 0.0 (0.0) 0 1.5 (0.5) 0 0.0001*
FOG item of the GABS (item 22) 0.1 (0.6) 0 0.4 (1.1) 0 0.024*
Number of falls in the last 12 months 2.2 (6.8) 0 4.1 (10.4) 0 0.21
FES-I score 23.4 (11.3) 18.5 29.8 (14.0) 21 0.01*
BBS score 49.9 (8.3) 52 46.8 (7.8) 51 0.01*
GABS 14.8 (13.9) 15 25.3 (14.6) 19 0.0001*
GABS timed tasks
Walking 5 meters 7.0 (2.6) 6.4 9.2 (5.3) 7.1 0.01*
Number of steps 11.3 (3.2) 11 14.1 (6.2) 12 0.006*
Cadence 1.6 (0.2) 1.6 1.6 (0.2) 1.6 0.6
Walking as fast as possible (5 meters) 5.5 (2.4) 5.2 6.6 (3.9) 5.5 0.1
Stand-walk-sit (10 meters) 19.4 (7.2) 17.4 23.9 (12.5) 18.8 0.03*
Table 1. Clinical and demographic characteristics of Parkinson’s disease patients with and without FOG.
FOG: Freezing of gait; PD: Parkinson’s disease; sUPDRSm: shortened UPDRS motor scale; FOG-Q: freezing of gait questionnaire; UPDRS: unified Parkinson’s 
disease rating scale; GABS: gait and balance scale; FES-I: falls efficacy scale international; BBS: Berg balance scale; SD: standard deviation.
*Mann-Whitney test: significance level <0.05.
Correlation 
coefficients (rs)
p-value
Disease duration 0.44 0.0001*
Age -0.21 0.024*
Number of falls in the last 12 
months 0.21 0.027*
FES-I 0.32 0.001*
SE score -0.28 0.004*
HY stage 0.22 0.02*
sUPDRSm (axial items) 0.35 0.0001*
sUPDRSm 0.16 0.1
GABS 0.37 0.0001*
BBS -0.27 0.005*
UPDRS Part II (ADL-FOG) (item 14) 0.79 0.0001*
FOG item of the GABS (item 22) 0.36 0.0001*
GABS timed tasks 
Walking 5 meters 0.21 0.02*
Stand-walk-sit (10 meters) 0.20 0.03*
Number of steps 0.19 0.04*
Walking as fast as possible 
(5 meters) 0.11 0.24
Cadence -0.10 0.28
Table 2. Correlation coefficients for the freezing of gait 
questionnaire.
HY: Hoehn and Yahr; SE: Schwab and England Scale; sUPDRSm: shortened 
UPDRS motor scale; FOG-Q: freezing of gait questionnaire; UPDRS: unified 
Parkinson’s disease rating scale; GABS: gait and balance scale; FES-I: 
falls efficacy scale international; BBS: Berg balance scale; *FOG-Q score 
significantly correlated.
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FOG-Q score significantly correlated with duration of dis-
ease, age, number of falls over the previous 12 months, HY 
stage, FES-I, SE, BBS and GABS scores. It also correlated with 
most GABS timed tasks, except for cadence and time to walk 
five meters as fast as possible. The FOG-Q presented better 
correlated with axial items of the sUPDRSm than with the 
total sUPDRSm score.
The FOG-Q score had a significant and strong correlation 
with the freezing item of the UPDRS (rs=0.79; p<0.0001) but a 
poor to moderate correlation with the freezing items of the 
GABS (rs=0.36; p<0.0001).
The area under the ROC curve for the FOG-Q was 0.94 
(0.90–0.99). With a cut-off score of 4 points, the scale had sen-
sitivity and specificity of 0.90 and 0.92, respectively. Moreover, 
when the area under the ROC curve, sensitivity and speci-
ficity was calculated only for the item 3 of FOG-Q we found 
similar results. With a cut-off score of 1 point, the area under 
the ROC curve was 0.92, and the item had a sensitivity of 0.92 
and a specificity of 0.92.
Item 3 of the FOG-Q (score >0) identified 47.6% of PD 
patients as freezers, while the item 14 of UPDRS Part II 
(ADL-FOG) identified 43.92% and the FOG item of the 
GABS (item 22) 13.08%. This last item obtained a Kappa val-
ue of 0.158, demonstrating a slight agreement among the 
other two items, while between the item 14 of UPDRS Part 
II (ADL-FOG) and item 3 of the FOG-Q obtained Kappa of 
0.88, which indicates excellent agreement.
DISCUSSION
FOG is a frequent clinical problem in patients with PD12,13. 
Our study found that around 47% of patients with PD that 
attended a Brazilian specialized movement disorder clin-
ic reported FOG. Other previous studies reported vari-
able findings, and this large variability may be probably ex-
plained by methodological differences such as the criteria 
to identify FOG and by the clinical characteristics of the 
sample evaluated14-16.
Our patients with PD and FOG had a longer disease du-
ration compared to patients without it, which is consonant 
with previous studies showing a strong association between 
FOG and the duration and severity of the disease4,17. They 
tended to be younger than those without FOG, which dis-
agrees with previous findings showing that the frequency of 
FOG increases with age17,18. This may be possibly explained 
by the characteristics of our sample, recruited from a special-
ized clinic with younger and more severely affected patients.
As expected, our patients with FOG had increased fear 
of falling as measured by the FES-I. The fear of future falls 
restricts daily activities and mobility, which can lead to oth-
er complications, such as social isolation, depression and 
poor sleep quality19.
The Brazilian version of the FOG-Q that we proposed 
to validate had high internal consistency and test-retest re-
liability that were very similar to those described by other 
studies4,20. This demonstrated that this version is a reliable 
and valid tool to assess FOG in PD.
The score of the FOG-Q correlated with measures of bal-
ance, gait and with the severity of the axial symptoms of PD. 
The convergent and divergent reliability of the Brazilian ver-
sion of the FOG-Q was very similar to that observed in other 
studies, showing that patients with PD and FOG have more 
balance and gait problems and worse parkinsonian axial mo-
tor signs17,21. Because these symptoms directly interfere with 
mobility and social life, this may be one way by which FOG 
negatively affects quality of life22,23.
In contrast with previous studies, we found no signifi-
cant correlations between the score of the Brazilian ver-
sion of the FOG-Q and the total score of the sUPDRSm4,20. 
However, this could be explained by the summarized char-
acter of this brief scale.
The correlation found between the FOG-Q and item 
22 of the GABS was poor, with the latter identifying only 13% 
of our population of PD patients as freezers. This result was 
much lower when compared to the FOG-Q and item 14 of 
the UPDRS Part II (ADL-FOG). Item 22 of the GABS is a di-
rect and objective measure where FOG is scored after trying 
to evoke a freezing episode in different situations during the 
clinical evaluation, while item 14 of the UPDRS Part II (ADL-
FOG) and the FOG-Q are clinical questions that subjectively 
try to identify the phenomenon based on clinical informa-
tion. We may conclude that in a clinical setting it is very diffi-
cult to reproduce a freezing episode due to its variability and 
unpredictability1.
When simple questions, item 3 of the FOG-Q and item 14 
of UPDRS Part II (ADL-FOG), was compared to the FOG-Q 
total score, we observed similar results for the diagnosis of 
FOG. This suggests that the whole scale do not improve the 
screening of FOG. However, the FOG-Q is a very useful tool 
to quantify the severity of FOG episodes in patients with PD 
and to assess the efficacy of interventional studies, which jus-
tifies the use of the scale4,24.
Recently, new versions of the FOG-Q were made avail-
able. Nilsson et al.25 validated a self-administered version of 
the FOG-Q with good results compared to the original scale. 
Therefore, this version facilitates the investigation of FOG in 
mail-based surveys and clinical practice. Nonetheless, the re-
liability of this version in patients with different educational 
levels remains to be tested. Another version was developed 
by Nieuwboer et al.26 and, in this case, the authors excluded 
the two items concerning gait difficulties and included ques-
tions about the impact of FOG on daily life.
The question of which is the best tool to identify FOG 
remains unanswered, and while we do not develop an 
automatic and continuous system to record locomotion 
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and quantify FOG, the FOG-Q may successfully be used 
for that purpose. One of the limitations of the FOG-Q 
is that FOG is quantified according to patients’ self-re-
ports, and as shown in the study of Nieuwboer et al.26 pa-
tients tend to spontaneously underestimate the severity 
of FOG. However, the FOG-Q may also help to recognize 
and differentiate FOG from turning difficulties and off-
state akinesia27.
In conclusion, the Brazilian version of the FOG-Q was 
shown to be a valid tool to assess FOG in patients with PD, as 
well as to have internal consistency and test-retest reliability 
similar to other versions of the scale.
